New Thought Leader for Agilent

Skip to Navigation

Blog Post

  • Published: May 4, 2016
  • Author: Jon Evans
  • Suppliers: Agilent Technologies
  • Channels: Laboratory Informatics / Proteomics & Genomics / Gas Chromatography / Sample Preparation / Electrophoresis / Ion Chromatography / HPLC / Detectors / Proteomics / MRI Spectroscopy / Chemometrics & Informatics / X-ray Spectrometry / NMR Knowledge Base / Raman / Infrared Spectroscopy / Atomic / Base Peak / UV/Vis Spectroscopy

View comments on this post

Agilent Technologies has presented its latest Thought Leader Award to Shilin Chen, director of the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences in Beijing. Agilent's Thought Leader program promotes fundamental scientific advances by contributing financial support, products and expertise to the research of influential thought leaders in the life sciences and chemical analysis.

The award will fund Chen’s use of integrated biology – including various multi-omic solutions from Agilent – to generate important biological data sets related to the biosynthesis of bioactive compounds from herbs such as artemisinin and glycyrrhizin. Through this research, Chen hopes to advance understanding of the mechanisms by which herbal medicines disrupt diseases and to identify relevant biomarkers, which could then point the way to new drug discovery.

“We are delighted to receive an Agilent Thought Leader Award. It will allow us to incorporate integrated experimental and bioinformatics approaches to traditional Chinese medicine,” said Chen. “Our group is focusing on dissecting and understanding the biosynthesis and regulatory mechanisms responsible for specific metabolic processes generated by natural herbs. We have initiated the herbal genomic project, and Agilent’s innovative technologies and unique solutions can provide new tools and approaches to help us combine metabolomics and genomics in the study of traditional Chinese medicine. We are looking forward to working collaboratively with Agilent scientists to accelerate the discovery and characterization of new medicines.”

“We are pleased to support Dr. Chen’s efforts in the systems-level analysis of herbal metabolic processes using integrated omics approaches,” said Teng Chai Hock, vice president and general manager of Agilent’s Life Sciences and Applied Markets Group in Greater China. “Dr. Chen’s research is a prime example of continued innovation in traditional Chinese medicine through the application of advanced analytical methods.”

(Photo of Shilin Chen courtesy of the Institute of Chinese Materia Medica.)


There are currently no comments on this post.

Comment Form

You have to log in to comment on this post.

Log in using the form at the top of the page or register here.

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in separation science? Visit our sister site

Copyright © 2018 John Wiley & Sons, Inc. All Rights Reserved